Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination

Vaccines are among the most effective public health tools for combating certain infectious diseases such as influenza. The role of the humoral immune system in vaccine-induced protection is widely appreciated; however, our understanding of how antibody specificities relate to B cell function remains limited due to the complexity of polyclonal antibody responses. To address this, we developed the Spec-seq framework, which allows for simultaneous monoclonal antibody (mAb) characterization and transcriptional profiling from the same single cell. Here, we present the first application of the Spec-seq framework, which we applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor (BCR) isotype and vaccine reactivity. Our analysis did not find evidence of long-term transcriptional specialization between plasmablasts of different isotypes. However, we did find enhanced transcriptional similarity between clonally related B cells, as well as distinct transcriptional signatures ascribed by BCR vaccine recognition. These data suggest IgG and IgA vaccine–positive plasmablasts are largely similar, whereas IgA vaccine–negative cells appear to be transcriptionally distinct from conventional, terminally differentiated, antigen-induced peripheral blood plasmablasts.

[1]  Ludvig M. Sollid,et al.  Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins , 2017, Cell reports.

[2]  Karlynn E. Neu,et al.  Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation , 2017, Science Immunology.

[3]  Karlynn E. Neu,et al.  Refined protocol for generating monoclonal antibodies from single human and murine B cells. , 2016, Journal of immunological methods.

[4]  Aly A. Khan,et al.  BASIC: BCR assembly from single cells , 2016, Bioinform..

[5]  Cornelia L Dekker,et al.  Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching , 2016, eLife.

[6]  L. Sollid,et al.  The human intestinal B-cell response , 2016, Mucosal Immunology.

[7]  T. Kepler,et al.  B-Cell Selection in Germinal Centers Elicited by Complex Antigens , 2016, Journal of Immunology.

[8]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[9]  IV FrederickA.Matsen,et al.  Likelihood-Based Inference of B Cell Clonal Families , 2016, PLoS Comput. Biol..

[10]  L. Pachter,et al.  Fast and accurate single-cell RNA-seq analysis by clustering of transcript-compatibility counts , 2016, bioRxiv.

[11]  M. V. van Zelm,et al.  The forkhead transcription factor FOXP1 represses human plasma cell differentiation. , 2015, Blood.

[12]  Sarah A Teichmann,et al.  Computational assignment of cell-cycle stage from single-cell transcriptome data. , 2015, Methods.

[13]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[14]  J. Treanor,et al.  Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine. , 2015, Vaccine.

[15]  M. Rose Mucosal immunization in perspective , 2014, Human vaccines & immunotherapeutics.

[16]  B. Greenwood The contribution of vaccination to global health: past, present and future , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[17]  Jim Euchner Design , 2014, Catalysis from A to Z.

[18]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[19]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[20]  Kai-Ting C. Shade,et al.  Antibody Glycosylation and Inflammation , 2013 .

[21]  George Georgiou,et al.  High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire , 2013, Nature Biotechnology.

[22]  O. Pabst New concepts in the generation and functions of IgA , 2012, Nature Reviews Immunology.

[23]  P. Wilson,et al.  Tools to therapeutically harness the human antibody response , 2012, Nature Reviews Immunology.

[24]  N. S. Laursen,et al.  Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.

[25]  Tadaki Suzuki,et al.  Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. , 2012, Vaccine.

[26]  A. Adegnika,et al.  Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination , 2011, Molecular & Cellular Proteomics.

[27]  Frédéric Delsuc,et al.  MACSE: Multiple Alignment of Coding SEquences Accounting for Frameshifts and Stop Codons , 2011, PloS one.

[28]  H. Wardemann,et al.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. , 2011, The Journal of clinical investigation.

[29]  J. Yewdell,et al.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of Experimental Medicine.

[30]  R. Compans,et al.  Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection , 2010, PloS one.

[31]  S. Plotkin Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[32]  Andreas Radbruch,et al.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses. , 2009, Blood.

[33]  J. D. Capra,et al.  Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen , 2009, Nature Protocols.

[34]  J. Novak,et al.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding. , 2008, Biochemistry.

[35]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[36]  T. Ichinohe,et al.  Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine , 2007, The Journal of infectious diseases.

[37]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[38]  J. Woof,et al.  Mucosal immunoglobulins , 2005, Immunological reviews.

[39]  Shigeru Iida,et al.  Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.

[40]  L. Staudt,et al.  XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. , 2004, Immunity.

[41]  S. Chen‐Kiang Cell‐cycle control of plasma cell differentiation and tumorigenesis , 2003, Immunological reviews.

[42]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[43]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[44]  Jamin,et al.  Glycosylation of Immunoglobulin A Influences Its Receptor Binding , 1999, Scandinavian journal of immunology.

[45]  P. Delves,et al.  The effect on IgG glycosylation of altering beta1, 4-galactosyltransferase-1 activity in B cells. , 1998, Glycobiology.

[46]  D. Scott,et al.  Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas. , 1996, Molecular biology of the cell.

[47]  M. Kerr,et al.  The structure and function of human IgA. , 1990, The Biochemical journal.

[48]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[49]  M. Wormald,et al.  Glycosylation and Fc receptors. , 2014, Current topics in microbiology and immunology.

[50]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[51]  D. James,et al.  Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.

[52]  S. Iida,et al.  Establishment of FUT 8 Knockout Chinese Hamster Ovary Cells : An Ideal Host Cell Line for Producing Completely Defucosylated Antibodies With Enhanced Antibody-Dependent Cellular Cytotoxicity , 2004 .

[53]  B. Murphy,et al.  Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. , 1995, Vaccine.